A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability

A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability

Andrea Becciolini,1 Maria Gabriella Raimondo,2 Chiara Crotti,2 Elena Agape,2 Martina Biggioggero,2 Ennio Giulio Favalli1 1Department of Rheumatology, 2Department of Clinical Sciences and Health Community, University of Milan, Division of Rheumatology, Gaetano Pini Institute, Milan, Italy Abstract:...

Full description

Bibliographic Details
Main Authors: Becciolini A, Raimondo MG, Crotti C, Agape E, Biggioggero M, Favalli EG
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Drug Design, Development and Therapy
Subjects:
biologic therapy
biosimilars
interchangeability
TNF inhibitors
rheumatic diseases
Online Access:https://www.dovepress.com/a-review-of-the-literature-analyzing-benefits-and-concerns-of-inflixim-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/a-review-of-the-literature-analyzing-benefits-and-concerns-of-inflixim-peer-reviewed-article-DDDT

Similar Items